JP2004533462A5 - - Google Patents

Download PDF

Info

Publication number
JP2004533462A5
JP2004533462A5 JP2003503221A JP2003503221A JP2004533462A5 JP 2004533462 A5 JP2004533462 A5 JP 2004533462A5 JP 2003503221 A JP2003503221 A JP 2003503221A JP 2003503221 A JP2003503221 A JP 2003503221A JP 2004533462 A5 JP2004533462 A5 JP 2004533462A5
Authority
JP
Japan
Prior art keywords
acid
nitrooxymethyl
acetyloxy
ester
methylpyridinyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003503221A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004533462A (ja
Filing date
Publication date
Priority claimed from IT2001MI001240A external-priority patent/ITMI20011240A1/it
Application filed filed Critical
Publication of JP2004533462A publication Critical patent/JP2004533462A/ja
Publication of JP2004533462A5 publication Critical patent/JP2004533462A5/ja
Pending legal-status Critical Current

Links

JP2003503221A 2001-06-13 2002-05-28 血管症の治療のための有機ナイトレートをベースとする化合物 Pending JP2004533462A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2001MI001240A ITMI20011240A1 (it) 2001-06-13 2001-06-13 Farmaci per le vasculopatie
PCT/EP2002/005846 WO2002100400A1 (en) 2001-06-13 2002-05-28 Organic nitrate-based compounds for the treatment of vasculopathies

Publications (2)

Publication Number Publication Date
JP2004533462A JP2004533462A (ja) 2004-11-04
JP2004533462A5 true JP2004533462A5 (https=) 2005-12-22

Family

ID=11447858

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003503221A Pending JP2004533462A (ja) 2001-06-13 2002-05-28 血管症の治療のための有機ナイトレートをベースとする化合物

Country Status (7)

Country Link
US (1) US20040171592A1 (https=)
EP (1) EP1406613B1 (https=)
JP (1) JP2004533462A (https=)
DE (1) DE60223810T2 (https=)
ES (1) ES2296964T3 (https=)
IT (1) ITMI20011240A1 (https=)
WO (1) WO2002100400A1 (https=)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2393724A1 (en) 1999-12-23 2001-06-28 Nitromed, Inc. Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
WO2003103602A2 (en) 2002-06-11 2003-12-18 Nitromed, Inc. Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
ITMI20021399A1 (it) * 2002-06-25 2003-12-29 Nicox Sa Inibitori della cicloossigenasi 2
AU2003279622A1 (en) * 2002-06-28 2004-01-19 Nitromed, Inc. Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use
CA2491127A1 (en) 2002-07-03 2004-01-15 Nitromed, Inc. Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
AU2003261281A1 (en) 2002-07-29 2004-02-16 Nicox S.A. Cyclooxygenase- 2 selective inhibitors, compositions and methods of use
US7169805B2 (en) * 2003-05-28 2007-01-30 Nicox S.A. Captopril derivatives
US20080293781A1 (en) 2005-11-23 2008-11-27 Alberto Gasco Salicylic Acid Derivatives
WO2009007230A1 (en) 2007-07-09 2009-01-15 Nicox S.A. Use of nitric oxide releasing compounds in the treatment of chronic pain
KR101356082B1 (ko) * 2011-11-18 2014-01-29 한국식품연구원 코니페릴 알코올을 포함하는 hTRPA1 활성화 조성물 및 그의 용도
CN104341358B (zh) * 2013-07-25 2016-05-18 昆药集团股份有限公司 一种化合物及其制备方法与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI0759899T1 (en) * 1994-05-10 1999-12-31 Nicox S.A. Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic acitivities
IT1276071B1 (it) * 1995-10-31 1997-10-24 Nicox Ltd Compositi ad attivita' anti-infiammatoria
IT1308633B1 (it) * 1999-03-02 2002-01-09 Nicox Sa Nitrossiderivati.
IT1311924B1 (it) * 1999-04-13 2002-03-20 Nicox Sa Composti farmaceutici.
RU2303373C2 (ru) * 2000-04-14 2007-07-27 Марс, Инкорпорейтед Композиции и способы улучшения состояния сосудистой системы
IT1319201B1 (it) * 2000-10-12 2003-09-26 Nicox Sa Farmaci per il diabete.
IT1319202B1 (it) * 2000-10-12 2003-09-26 Nicox Sa Farmaci per le malattie a base infiammatoria.

Similar Documents

Publication Publication Date Title
JP2004533462A5 (https=)
RU2003121236A (ru) Арилированные амиды фуран- и тиофенкарбоновых кислот с блокирующим калиевый канал действием
JP2018536641A5 (https=)
DK1396270T3 (da) Borsyresalte
IS7102A (is) Taxól-eflandi efnasambönd
RU2006137706A (ru) 9-замещенное производное 8-оксоаденина
ATE416159T1 (de) Kristall für ein orales, festes arzneimittel, und ein orales, festes arnzeimittel zur behandlung von dysurie, das diesen enthält
MY135954A (en) Crystalline form of (s)-ethoxy-3-4-(2-4-methanesulfonyloxyphenyl ethoxy) phenyl] propanoic acid
SE9904413D0 (sv) Comminuted form
RU94045270A (ru) Применение соединений для ингибирования окисления лдл, подавления атеросклероза, ишемической болезни сердца, супероксидных анионов и других кислород-реактивных промежуточных продуктов, конечных продуктов повышенного гликозилирования
JP2005522472A5 (https=)
GEP20074058B (en) 4-(7-halo-2-quino(xa) linyloxy-phenoxy-propionic acid derivatives as antineoplastic agents
RU2004103475A (ru) Производные арил-или гетероарилазолилкарбинолов для лечения недержания мочи
NO20050667L (no) N-substituerte-1H-indol-5-propionsyreforbindelser som PPAR agonister nyttige for behandling av diabetes
US20040171592A1 (en) Organic nitrate-based compounds for the treatment of vasculopathies
FR2865732B1 (fr) Composes de type hydrazide et leur utilisation dans des compositions pharmaceutiques pour le traitement des maladies cardiovasculaires
EP1310485A4 (en) Pyrrole derivatives
ATE358128T1 (de) Vorbeugende oder therapeutische mittel gegen gastrische oder ösophageale regurgitation
WO2003013499A2 (en) Drugs for vasculopaties
RU2004124378A (ru) Производные карбоксамидина и их использование при лечении заболеваний сосудов
AR054770A1 (es) Oxoindoles como inhibidores de quinasas, un metodo para su elaboracion, composiciones farmaceuticas que los contienen y su preparacion, un juego de elementos que los utiliza y su uso en la fabricacion de medicamentos para el tratamiento de enfermedades mediadas por proteinas quinasas mek1 o mek2.
DE60009517D1 (de) A-500359-derivate
MXPA01007705A (es) Derivado de benzamida y medicamento que lo contiene.
JP2003238406A5 (https=)
NO20076251L (no) Nye DHA derivater og deres anvendelse som medikamenter